GZYK(SZ:002524) Xin Lang Cai Jing·2025-10-31 01:07Core Viewpoint - Guangzheng Eye Hospital, established in December 2001 and listed in December 2010, operates in the domestic ophthalmology medical service sector with a chain operation model, possessing brand and scale advantages [1] Group 1: Business Performance - In Q3 2025, Guangzheng Eye Hospital reported revenue of 663 million yuan, ranking 12th in the industry, significantly lower than the top player Aier Eye Hospital's 17.484 billion yuan and the industry average of 2.966 billion yuan [2] - The main business composition includes cataract projects generating 148 million yuan (33.82%) and refractive projects generating 143 million yuan (32.71%) [2] - The net profit for the same period was 380,000 yuan, ranking 11th in the industry, far behind Aier Eye Hospital's 3.367 billion yuan and the industry average of 290 million yuan [2] Group 2: Financial Ratios - As of Q3 2025, Guangzheng Eye Hospital's debt-to-asset ratio was 89.56%, up from 80.68% year-on-year, significantly higher than the industry average of 46.74%, indicating substantial debt pressure [3] - The gross profit margin for Q3 2025 was 36.41%, slightly down from 36.90% year-on-year but still above the industry average of 31.10%, reflecting a competitive profitability position [3] Group 3: Shareholder Information - As of September 30, 2025, the number of A-share shareholders decreased by 11.99% to 38,700, while the average number of circulating A-shares held per shareholder increased by 14.07% to 13,200 [5] - Among the top ten circulating shareholders, Noan Multi-Strategy Mixed A ranked third with 3.6956 million shares, an increase of 1.3827 million shares from the previous period [5]